Related Experiment Video
Updated: Oct 15, 2025

An Orthotopic Endometrial Cancer Model with Retroperitoneal Lymphadenopathy Made From In Vivo Propagated and Cultured VX2 Cells
Published on: September 12, 2019
Increasing global accessibility to high-level treatments for cervical cancers
C Chargari1, M Arbyn2, A Leary3
1Radiation Oncology, Gustave Roussy Cancer Campus, Villejuif, France; Inserm U-1030, Université Paris-Saclay, Le Kremlin-Bicêtre, France.
Human papillomaviruses (HPV)-related gynecological cancers, especially cervical cancer, pose significant global health challenges. Improving access to modern, evidence-based treatments and multidisciplinary care is crucial for better outcomes and quality of life.
Area of Science:
- Gynecologic Oncology
- Public Health
- Cancer Treatment
Background:
- Human papillomaviruses (HPV) drive gynecological cancers, a major cause of cancer mortality in low- and middle-income countries (LMIC).
- The World Health Organization (WHO) initiated a cervical cancer elimination program focusing on screening and vaccination.
- Ensuring optimal care for women with invasive cervical cancer is a critical complementary goal.
Purpose of the Study:
- To highlight the complexities and essential components of modern cervical cancer treatment.
- To identify strategies for improving treatment quality and accessibility, particularly in LMICs.
- To emphasize the need for evidence-based, multidisciplinary approaches to enhance oncological outcomes and quality of life.
Main Methods:
- Review of current cervical cancer treatment modalities, including surgery, radiotherapy (external-beam and brachytherapy), and chemotherapy.
- Analysis of international guidelines and multidisciplinary discussion protocols for standardizing care.
- Exploration of strategies for quality improvement, such as mentorship, training, and international cooperation.
Main Results:
- Standard treatment is multimodal, requiring specialized facilities and expertise, which are often lacking in LMICs.
- International cooperation, education, and technical support are vital for upgrading radiotherapy/brachytherapy services and systemic treatment access in LMICs.
- Adherence to established standards and integrative, multidisciplinary care is essential for improving cure rates while minimizing quality of life impairment.
Conclusions:
- Addressing the global burden of HPV-related gynecological cancers requires a concerted effort to provide equitable access to high-quality, evidence-based treatment.
- Investment in infrastructure, training, and international collaboration is necessary to overcome disparities in cancer care, particularly in resource-limited settings.
- Multidisciplinary and integrative approaches are key to optimizing patient outcomes and enhancing quality of life in cervical cancer management.
Related Concept Videos
Cancer Vaccines
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Treatment Resistant Cancers
Targeted Cancer Therapies
There are several types of targeted therapies against...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...

